AU2202792A - Specific inhibition of dihydrofolate reductase and compounds therefor - Google Patents

Specific inhibition of dihydrofolate reductase and compounds therefor

Info

Publication number
AU2202792A
AU2202792A AU22027/92A AU2202792A AU2202792A AU 2202792 A AU2202792 A AU 2202792A AU 22027/92 A AU22027/92 A AU 22027/92A AU 2202792 A AU2202792 A AU 2202792A AU 2202792 A AU2202792 A AU 2202792A
Authority
AU
Australia
Prior art keywords
dihydrofolate reductase
specific inhibition
compounds therefor
therefor
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU22027/92A
Other versions
AU657348B2 (en
Inventor
Jeffrey M Blaney
Ivan Kompis
Charles K Marlow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Novartis Vaccines and Diagnostics Inc
Original Assignee
F Hoffmann La Roche AG
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Chiron Corp filed Critical F Hoffmann La Roche AG
Assigned to CHIRON CORPORATION, F. HOFFMANN-LA ROCHE AG reassignment CHIRON CORPORATION Alteration of Name(s) of Applicant(s) under S113 Assignors: KOMPIS, IVAN, PROTOS CORPORATION
Publication of AU2202792A publication Critical patent/AU2202792A/en
Application granted granted Critical
Publication of AU657348B2 publication Critical patent/AU657348B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AU22027/92A 1990-11-14 1992-08-31 Specific inhibition of dihydrofolate reductase and compounds therefor Ceased AU657348B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US730691 1985-05-02
US61361990A 1990-11-14 1990-11-14
US613619 1990-11-14
US73069191A 1991-07-16 1991-07-16

Publications (2)

Publication Number Publication Date
AU2202792A true AU2202792A (en) 1994-04-28
AU657348B2 AU657348B2 (en) 1995-03-09

Family

ID=27087063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22027/92A Ceased AU657348B2 (en) 1990-11-14 1992-08-31 Specific inhibition of dihydrofolate reductase and compounds therefor

Country Status (7)

Country Link
EP (1) EP0639075A1 (en)
JP (1) JPH07509215A (en)
AU (1) AU657348B2 (en)
CA (1) CA2095518A1 (en)
IE (1) IE913974A1 (en)
PT (1) PT99514B (en)
WO (1) WO1992008461A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721242A (en) * 1993-06-17 1998-02-24 Hoffmann-La Roche Inc. Antibiotic combination
BR9509768A (en) * 1994-11-24 1998-07-07 Hoffmann La Roche New benzyl pyrimidines
TW438796B (en) * 1996-05-15 2001-06-07 Hoffmann La Roche 2,4-diaminopyrimidine derivatives, the manufacture process thereof, and the antibiotically-active pharmaceutical composition containing the same
WO1998037898A1 (en) * 1997-02-24 1998-09-03 Barclay Barry J Synergistically acting anti-fungal agents that are inhibitors of folate metabolism, especially methotrexate and sulfamethoxazole
BR0010909A (en) 1999-05-24 2002-02-19 Sankyo Co Pharmaceutical composition, agent that has apoptosis-inducing activity, and, use of a fas anti-human antibody
US8853228B2 (en) * 2007-06-04 2014-10-07 University Of Connecticut Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2658897A (en) * 1951-06-27 1953-11-10 Burroughs Wellcome Co 2, 4-diamino-5-benzyl pyrimidines
FR1090394A (en) * 1953-03-11 1955-03-30 Wellcome Found Pyrimidine derivatives and their manufacture
US2852450A (en) * 1954-06-10 1958-09-16 Donnelley & Sons Co Method of copper plating
FR1292920A (en) * 1959-04-18 1962-05-11 Wellcome Found Pyrimidine derivatives and their preparation
GB1142654A (en) * 1965-10-28 1969-02-12 Wellcome Found Cyano-acetals and their use in benzylpyrimidine synthesis
FR94837E (en) * 1966-02-19 1969-11-28 Wellcome Found Process for the preparation of pyrimidine derivatives.
GB1181657A (en) * 1966-03-31 1970-02-18 Ici Ltd Pyrimidine Derivatives and Compositions Containing them
BE793253A (en) * 1971-12-23 1973-04-16 Lepetit Spa NEW BACTERICIDE COMPOSITIONS AND THEIR USE
CH591457A5 (en) * 1973-11-08 1977-09-15 Hoffmann La Roche
DE2617967C3 (en) * 1976-04-24 1978-11-02 Nordmark-Werke Gmbh, 2000 Hamburg Process for the preparation of 2,4-diamino-5-benzylpyrimidines
IE45427B1 (en) * 1976-07-09 1982-08-25 American Home Prod Pyrrold 3,2if quinazoline-1,3-diamine and related compounds
LU77269A1 (en) * 1977-05-05 1979-01-18
LU77268A1 (en) * 1977-05-05 1979-01-18
GR71725B (en) * 1977-11-10 1983-06-22 Hoffmann La Roche
US4233445A (en) * 1979-07-05 1980-11-11 American Home Products Corporation 7-(Substituted)-7H-pyrrolo[3.2-F]-quinazoline-1,3-diamines
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
OA07362A (en) * 1980-10-27 1984-06-30 May & Baker Ltd Pyrimidine derivatives, process for their preparation and compositions containing them.
ZA818204B (en) * 1980-11-27 1983-07-27 Wellcome Found Antibacterial benzylpyrimidines
US4451466A (en) * 1982-07-02 1984-05-29 Shell Oil Company Use of pyrroloquinazolinediamines as pesticides
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GR80171B (en) * 1983-08-29 1985-01-02 Ciba Geigy Ag N-(2-nitrophenyl)-4-aminopyrimidine derivatives process for the preparation thereof and use
US4501890A (en) * 1983-09-26 1985-02-26 Eli Lilly And Company Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines
DE3417264A1 (en) * 1984-05-10 1985-11-14 Bayer Ag, 5090 Leverkusen NEW 2,4-DIAMINO-6-HALOGEN-5-ALKYLTHIO-PYRIMIDINE
DE3701277A1 (en) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh NEW TRICYCLIC BENZIMIDAZOLES, METHOD FOR THEIR PRODUCTION AND USE AS MEDICINAL PRODUCTS
US4996198A (en) * 1988-07-11 1991-02-26 Hoffmann-La Roche Inc. Anticoccidial composition

Also Published As

Publication number Publication date
EP0639075A1 (en) 1995-02-22
AU657348B2 (en) 1995-03-09
WO1992008461A1 (en) 1992-05-29
JPH07509215A (en) 1995-10-12
CA2095518A1 (en) 1992-05-15
PT99514B (en) 1999-04-30
EP0639075A4 (en) 1993-09-29
IE913974A1 (en) 1992-05-20
PT99514A (en) 1992-10-30

Similar Documents

Publication Publication Date Title
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
CY1994A (en) Pharmaceutical compositions of pH at least 8 comprising an HMG-CoA reductase inhibitor
AU4267293A (en) Use of MMP inhibitors
AU7727591A (en) Method for preventing onset of restenosis after angioplasty employing pravastatin
AU5343394A (en) Orthosis and prosthesis
AU8726991A (en) Reduction or prevention of sensitization to drugs
PL306127A1 (en) Derivatives of epi-epibathydine
AU6710598A (en) Improved methods for the determination and adjustment of prolactin daily rhythms
AU3942893A (en) Total synthesis of taxol
ZA925946B (en) Tetrahydroindazole tetrahydrocyclopentapyrazole and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors
AU8551191A (en) Inhibition of scale
AU651992B2 (en) Polyethylene terephthalate compositions and methods of using thereof
AU2202792A (en) Specific inhibition of dihydrofolate reductase and compounds therefor
AU6723294A (en) Use of simmondsine
ZA969490B (en) Compounds useful for the inhibition of the replication of hiv-1 and hiv-1 mutants
AU3922493A (en) Inhibition of P70 S6 kinase
AU4532893A (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
AU7331194A (en) At-2 antagonist inhibition of vascular restenosis
JPS6426556A (en) Manufacture of novel intermediate and hmg-coa reductase inhibitor
PL306204A1 (en) Novel derivatives of imidazopyrimidine
AU2448292A (en) Pyrimidine derivative and weedkiller
AU2919192A (en) Piece of jewellery
AU3359493A (en) Determination of haptens
GB9318000D0 (en) Inhibition of vascular restenosis